There is No Distinctive Gut Microbiota Signature in the Metabolic Syndrome: Contribution of Cardiovascular Disease Risk Factors and Associated Medication

The gut microbiota (GM) has attracted attention as a new target to combat several diseases, including metabolic syndrome (MetS), a pathological condition with many factors (diabetes, obesity, dyslipidemia, hypertension, etc.) that increase cardiovascular disease (CVD) risk. However, the existence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortés-Martín, Adrián, Iglesias-Aguirre, Carlos E., Meoro, Amparo, Selma, María Victoria, Espín, Juan Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143903/
https://www.ncbi.nlm.nih.gov/pubmed/32183480
http://dx.doi.org/10.3390/microorganisms8030416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143903/
https://www.ncbi.nlm.nih.gov/pubmed/32183480
http://dx.doi.org/10.3390/microorganisms8030416

Ejemplares similares